A new study found that shingles vaccination was associated with slower epigenetic aging, lower inflammation, slower transcriptomic aging, and a lower composite biological aging score — with effects lasting more than four years. The mechanism is more interesting than the headline.
Most people think of the shingles vaccine as protection against a painful rash. That framing undersells it dramatically. A 2025 study published in *GeroScience* has reframed how longevity researchers should think about vaccination: not just as infection prevention, but as a biological age intervention with measurable effects on multiple aging clocks.
The findings are striking enough to deserve serious attention from anyone building a longevity protocol.
Kim and Crimmins (2025) analyzed data from the US Health and Retirement Study, a nationally representative longitudinal cohort of Americans over 50 that has been running since 1992. Their analysis covered 3,884 adults aged 70 and over, comparing those who had received the shingles vaccine against matched unvaccinated controls.
The study wasn't measuring whether vaccination prevented shingles outbreaks. It was asking a more fundamental question: does vaccination against the herpes zoster virus change how fast people age at the biological level?
The answer was yes — across five independent aging measures, all of them statistically significant.